Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Rinsulin R

PreclinicalSmall molecule

Rinsulin R is one of 45 small molecule programs targeting LAM. It is currently in Preclinical.

2

Indications

3

Total Trials

0

Active Trials

44

Competitors

Pipeline

Status by Indication[3][1]

Indication

LAMCompleted

TicsCompleted

LAMPreclinical

Completed

TicsPreclinical

Completed

Competition

Competitive Landscape

114 competitors in Tics

#DrugCompanyPhaseTrials

Sodium Valproate

Priftin

Nydrazid

KKaruna Therapeutics, Inc., a Bristol Myers Squibb company

Duvyzat

Dilaudid

RRhodes Pharmaceuticals, L.P.

CAB LA

Abexinostat

XXynomic Pharmaceuticals, Inc.

Cocaine Hydrochloride

Anaprazole

SSihuan Pharmaceutical Holdings Group Ltd.

Dostinex

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

LAM2 trials

Comparative Study of Rinsulin R (GEROPHARM) and Humulin Regular (Eli Lilly) Euglycemic Hyperinsulinemic Clamp Method

Completed·GGeropharm·N/A·NCT06050343·20 enrolled

Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method

Completed·GGeropharm·N/A·NCT04501250·52 enrolled

Tics1 trial

Comparative Study of the Pharmacokinetics of Rinsulin® Mix 30/70, Suspension for Subcutaneous Administration, 100 IU / ml (OJSC GEROPHARM-Bio, Russia) and Humulin® M3, Suspension for Subcutaneous Administration, 100 IU / ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method

Completed·GGeropharm·N/A·NCT04498884·32 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Rinsulin R. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Rinsulin R compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Rinsulin R. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Geropharm company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: GGeropharm

Related News